Risk factors for non-alcoholic fatty liver disease delineate the battlegrounds in optimizing disease prevention
Hepatobiliary Surg Nutr
.
2022 Jun;11(3):492-494.
doi: 10.21037/hbsn-22-3.
Authors
Igor Spivak
1
2
,
Eran Elinav
1
3
Affiliations
1
Systems Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
2
Medical Clinic III, University Hospital Aachen, Aachen, Germany.
3
Division of Cancer-Microbiome Research, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
PMID:
35693394
PMCID:
PMC9186184
DOI:
10.21037/hbsn-22-3
No abstract available
Publication types
Editorial
Comment